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recommendations for potentially 
practice changing evidence. 
BMJ Rapid Recommendations 
represent a collaborative effort 
between the MAGIC group (http://
magicproject.org/) and The 
BMJ. A summary is offered here 
and the full version including 
decision aids is on the MAGICapp 
(https://app.magicapp.org), for all 
devices in multilayered formats. 
Those reading and using these 
recommendations should consider 
individual patient circumstances, 
and their values and preferences 
and may want to use consultation 
decision aids in MAGICapp to 
facilitate shared decision making 
with patients. We encourage 
adaptation and contextualisation 
of our recommendations to local or 
other contexts. Those considering 
use or adaptation of content may 
go to MAGICapp to link or extract 
its content or contact The BMJ for 
permission to reuse content in this 
article.
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ABSTRACT
Clinical question Do adults with atraumatic shoulder pain for more than 3 months diagnosed as subacromial pain 
syndrome (SAPS), also labelled as rotator cuff disease, benefit from subacromial decompression surgery? This 
guideline builds on to two recent high quality trials of shoulder surgery.
Current practice SAPS is the common diagnosis for shoulder pain with several first line treatment options, 
including analgesia, exercises, and injections. Surgeons frequently perform arthroscopic subacromial 
decompression for prolonged symptoms, with guidelines providing conflicting recommendations.
Recommendation The guideline panel makes a strong recommendation against surgery.
How this guideline was created A guideline panel including patients, clinicians, and methodologists produced 
this recommendation in adherence with standards for trustworthy guidelines and the GRADE system. The 
recommendation is based on two linked systematic reviews on (a) the benefits and harms of subacromial 
decompression surgery and (b) the minimally important differences for patient reported outcome measures. 
Recommendations are made actionable for clinicians and their patients through visual overviews. These provide 
the relative and absolute benefits and harms of surgery in multilayered evidence summaries and decision aids 
available in MAGIC (www.magicapp.org) to support shared decisions and adaptation.
The evidence Surgery did not provide important improvements in pain, function, or quality of life compared with 
placebo surgery or other options. Frozen shoulder may be more common with surgery.
Understanding the recommendation The panel concluded that almost all informed patients would choose to avoid 
surgery because there is no benefit but there are harms and it is burdensome. Subacromial decompression 
surgery should not be offered to patients with SAPS. However, there is substantial uncertainty in what alternative 
treatment is best.
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physical therapy, exercise 
programmes, NSAIDs, 
and steroid injections  
Comparison of benefits and harms
Favours surgery Favours nonoperative management
StrongStrong WeakWeak





Recovery time varies from months to years and may include sick leave
No important difference
Day surgery with general anaesthesia and/or nerve block
After surgery, 2 weeks off work are typically needed
Avoid heavy lifting for one to three weeks, overhead 
activities for 3 months
635
The panel believes that all or almost all patients would place a high value on avoiding 




Global perceived effect Moderate
Evidence quality
Events per 1000 people
Events per 1000 people
Visual analogue scale (0–10)






At work Low859 818
Pain (Mean) High2.6 2.9
Function (Mean) High72 69
Quality of life (Mean) High0.70 0.73




Adults with shoulder   
   pain for more than 
      3 months
Does not apply to patients with:
Including:
Traumatic shoulder pain
Subacromial pain syndrome (SAPS)
Rotator cuff disease (RCD)
Other differential diagnoses
6
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U
p to a quarter of adults have experienced 
shoulder pain over the past year, and it 
represents the third most common muscu‑
loskeletal problem.1 2About half of those 
affected will recover completely within six 
months.3 Pain beyond three months is associated with 
poorer recovery, disability, and reduced ability to work.3
Subacromial pain is the most common form (up to 70%) 
of shoulder pain, and it can impair the ability to work or 
do household tasks.4‑6 Most patients presenting with 
subacromial pain, without a history of trauma, receive a 
diagnosis of subacromial pain syndrome (SAPS), shoul‑
der impingement, or rotator cuff disease. Each of these 
labels describe similar clinical presentations, but there 
is inconsistency about how they are defined and overlap 
between these diagnoses. Here, we use the term SAPS (see 
box 1 for details of its presentation). This recommendation 
addresses the role of surgery for adults with symptoms 
lasting more than three months, who approach health 
professionals for treatment.
This BMJ Rapid Recommendation is in response to two 
recent trials12 13 which found that subacromial decom‑
pression surgery provided no benefit over placebo 
surgery. The recommendation is based on two linked 
systematic reviews on benefits and harms of subacro‑
mial decompression surgery and minimally important 
differences in patient reported outcome measures for 
shoulder pain, function and quality of life.14 15 The main 
infographic provides an overview of the relative and abso‑
lute benefits and harms of surgery in standard GRADE for‑
mat. Box 2 shows all of the articles and evidence linked 
in this Rapid Recommendation package. Table 2 below 
shows evidence that has emerged since the publication 
of this article.
Current practice
First line treatment options for SAPS include simple 
analgesia such as paracetamol, non‑steroidal anti‑ 
inflammatory drugs (NSAIDs), glucocorticoid injections, 
and exercise therapy.8 Subacromial acromial decompres‑
sion surgery is a second line treatment option for patients 
with more longstanding symptoms. Current guidelines 
provide inconsistent recommendations (table 1). Such 
surgery includes removal of the subacromial bursa (bur‑
sectomy) and removal of bone from the under surface of 
the acromion (acromioplasty).8 Surgeons initially per‑
formed subacromial decompression surgery as an open 
procedure. It evolved to less invasive keyhole surgery: 
arthroscopy.
Despite trials dating back to 199318 and systematic 
reviews failing to demonstrate benefit from surgery,19 
the number of arthroscopies performed has risen dra‑
matically, although there is substantial geographical 
variation.20 21 There were 21 000 procedures performed 
in NHS hospitals in 2010, which cost approximately £50 
million.21
Box 1 | Details of subacromial pain syndrome (SAPS)
Common symptoms—Pain at the upper outer arm when 
lifting the arm (classically a painful arc through shoulder 
abduction), difficulty moving the arm (especially with 
forward flexion, external rotation, and abduction), 
reduced strength in the arm, and sleep problems due to 
pain7 8
Key differential diagnoses—Adhesive capsulitis (“frozen 
shoulder”) and glenohumeral osteoarthritis8 9
Imaging—Patients with SAPS can have degeneration and 
partial thickness rotator cuff tears or abnormalities in the 
subacromial bursa on imaging. These imaging findings are 
also common in people without symptoms10
Pathophysiology—Remains poorly understood. Cadaver 
studies suggested that pain might occur from rotator 
cuff tendons being caught (“impinging”) between 
the acromion or coracoacromial ligament and the 
humerus.11 These studies provided the initial rationale for 
subacromial decompression surgery
Table 1 | Major guideline recommendations on subacromial decompression surgery for 
subacromial pain syndrome (SAPS)*
Organisation Recommendation
European Society for Surgery of the Shoulder and the 
Elbow
No recommendation for or against subacromial surgery
British Elbow and Shoulder Society/British Orthopaedic 
Association 2015. Statement of upcoming update 2018†
Recommended in the absence of a rotator cuff 
tear if impingement symptoms fail to resolve with 
nonoperative treatment
Dutch Orthopaedic Association 201417 Not recommended
American Academy of Orthopaedic Surgeons, 2010 (AOA 
guidelines)
No recommendation for or against subacromial surgery, 
suggests initial nonoperative management
Australian Orthopaedic Association 2017 (AOA 
Statement 2017)
Recommended for significant and persistent symptoms 
unresponsive to nonoperative management (including 
injections and physiotherapy)
Canadian Medical Association and Canadian Orthopaedic 
Association-Arthroscopy Association of Canada
No recommendation for or against subacromial 
decompression surgery
*These guidelines have not included new evidence captured in our Rapid Recommendation.
†Accredited by National Institute of Clinical Excellence (NICE). A guideline update, based on the CSAW trial, has been 
announced.13
Box 2 | Linked articles in this BMJ Rapid Recommendation 
cluster
• Vandvik PO, Lähdeoja T, Ardern C, et al. Subacromial 
decompression surgery for adults with shoulder pain: a 
clinical practice guideline. BMJ 2019;364:l294
 – Summary of the results from the Rapid 
Recommendation process
•  Hao Q, Devji T, Zeraatkar D, et al. Minimal important 
differences for improvement in shoulder condition patient-
reported outcomes: a systematic review to inform a BMJ 
Rapid Recommendation. BMJ Open 2019; doi:10.1136/
bmjopen-2018-02877714
 – Review of minimally important differences in outcomes 
from shoulder conditions
• Lähdeoja T, Karjalainen T, Jokihaara J, et al. Subacromial 
decompression surgery versus conservative management 
in patients with shoulder pain: a systematic review with 
meta-analysis. Br J Sports Med 2019; doi:10.1136/
bjsports-2018-10048615
 – Review and meta-analysis of all available randomised 
trials that assessed effects of surgery for SAPS
• Karjalainen TV, Jain NB, Page CM, et al. Subacromial 
decompression surgery for rotator cuff disease. 
Cochrane Database Syst Rev 2019;(1):CD005619. 
doi:10.1002/14651858.CD005619.pub316
 – Updated Cochrane systematic review on subacromial 
decompression surgery for rotator cuff disease
• MAGICapp (www.magicapp.org/public/guideline/nBMa0L)
 – Expanded version of the results with multilayered 
recommendations, evidence summaries, and decision 
aids for use on all devices (see appendix 3 on bmj.com)
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NUMBER OF TRIALS 7 NUMBER OF PATIENTS 1014 
DATA SOURCES
Use this information to gauge how 
similar your patients’ conditions are
 to those of people studied in the trials
PATIENT CHARACTERISTICS
Previous treatments
Conservative treatments (including exercise
therapy, corticosteroid injections, and rest)
were variably applied by most patients





years prior to enrolment
20 40 80 10060
MEAN AGE
at baseline 
































3 6311 - 3 years
2 1564 - 8 years
2 2279 - 14 years
Risk of bias
2 506Low risk of bias
4 508High risk of bias
Setting
All included trials took place in hospital
outpatient clinics. 
* Data for mean symptom duration prior to enrollment comes from two trials (N=333)
Fig 2 |  Characteristics of 
participants and trials 
included in the systematic 
review of the effects of 
surgery for subacromial pain 
syndrome (SAPS)
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The evidence
What is the minimum difference in symptoms and 
function important to patients?
The systematic review of minimally important differences 
(MIDs) identified 22 original studies of 5562 patients. 
They reported results for 74 MID estimates judged to be 
of variable and mostly low credibility.14 The most credible 
MID estimates were used to help interpret the results of the 
systematic review, as shown in the infographic. 
The panel were, due to credible estimates, confident 
that patients valued 
•   A difference in pain of at least 1.5 units as important 
(visual analogue scale 0‑10) 
•   A difference in function of at least 8.3 units as 
important (constant score 0‑100)
The panel were less confident in the difference in health 
related quality of life reported by patients to be important 
(EQ 5‑D, MID 0.07 units, low credibility median estimate). 
What are the benefits and harms of subacromial 
decompression surgery?
The linked systematic review and meta‑analysis pooled 
data from seven randomised controlled trials with 
1014 participants diagnosed with SAPS.15 In general, 
the patients included in the trials are representative of 
patients with SAPS presenting to primary care centres 
and outpatient clinics (fig 2). Participants were around 
49 years (median) and had had symptoms for around two 
years (median).
Planned evaluation of trials at lower risk of bias
The panel planned to focus on evidence at lower risk of bias. 
Two trials included placebo surgery and were at low risk of 
bias.12 13 At one year after treatment, they showed that sur‑
gery did not have meaningful benefit over placebo surgery:
•   High certainty evidence for little or no effect on
 – Pain (mean difference −0.26 (95% confidence 
interval −0.84 to 0.33), MID 1.5)
 – Function (mean difference 2.8 (−1.4 to 6.9), MID 8.3)
 – Health related quality of life (mean difference 
−0.03 points (−0.11 to 0.06), MID 0.07)
•   Moderate certainty evidence for little or no global 
perceived effect (risk ratio 1.10 (0.94 to 1.30))
•   Low certainty evidence for little or no effect on return 
to work (risk ratio 1.05 (0.89 to 1.23)).
Similar results were seen at six months, two years, 
and at five year follow‑up, with the latter supported by 
low certainty evidence due to imprecise estimates from 
unblinded trials.15
Planned evaluation of surgery compared with exercise 
therapy
This analysis compared subacromial decompression sur‑
gery (including postoperative exercise therapy) with exer‑
cise therapy alone. Six trials reported such comparisons, 
and all were at high risk of bias due to lack of blinding. 
Some had imprecise estimates of effect. Compared with 
exercise therapy, there was no important benefit of surgery 
on pain, function, quality of life, global perceived effect, 
and return to work.15
About a third (32%) of all participants included in 
the trials continued to have more than minor symptoms 
(such as mild to moderate pain) at one year, irrespective 
of treatment. The average pain scores in the trials at two 
years were 1.6 to 3.0 units (0‑10 scale), reflecting mild to 
moderate pain.
Harms
Potential harms from surgery were incompletely reported 
in the trials. The trials were also underpowered to detect 
rare events. There were around 12 more frozen shoulders 
per 1000 patients undergoing subacromial decompres‑
sion surgery, based on the two placebo controlled trials 
(low certainty evidence).
Because harms data from randomised trials were antici‑
pated to be so limited, the guideline panel requested the 
systematic review to include observational studies 
designed to evaluate harms after subacromial decom‑
pression surgery.15 The systematic review assessed 140 
publications in full text, of which four reported results 
from a large prospective cohort study from the United 
States considered to represent best current evidence on 
serious harms.10‑22 This registry study investigated 30‑day 
complications resulting in readmission to hospitals after 
mixed arthroscopic procedures including subacromial 
decompression surgery from 2006 to 2013.9 23
HOW THIS RECOMMENDATION WAS CREATED
Our international panel included patients with lived experience of shoulder pain and surgery, 
orthopaedic surgeons, physiotherapists, a rheumatologist, general internists, a general 
practitioner, epidemiologists, and methodologists. No person had financial conflicts of 
interest; intellectual and professional conflicts were minimised and managed (see appendix 
1 on bmj.com for details of panel members and their competing interests). The panel initially 
decided on the scope of the recommendation and the outcomes that are most important to 
patients.
The panel identified the following important outcomes: pain, patient global perceived effect, 
physical function, participation in work and recreation activities, health related quality of life, 
development of full-thickness rotator cuff tears, and potential harms from surgery (such as 
frozen shoulder, death, infection, venous thromboembolism, and anaesthesia related events). 
This selection was also informed by the Outcome Measures in Rheumatology (OMERACT) 
preliminary shoulder trial core domain outcome set.28
To inform the recommendation the panel members requested two systematic reviews 
addressing the following questions:
1 What is the smallest change in pain, function and quality of life that patients with shoulder 
conditions such as SAPS consider important—the minimally important difference—to 
make surgery worthwhile? Such patient-reported outcomes measures (PROMs) were 
measured with a variety of instruments in the trials and are challenging to interpret.
2 What are the benefits and harms of subacromial decompression surgery in patients with 
SAPS, as compared to placebo and nonoperative management strategies?
Parallel teams conducted these systematic reviews.14 15 Another team updated a Cochrane 
systematic review synchronised with this BMJ Rapid Recommendation.16 The panel asked the 
review team to explore potential subgroup effects for risk of bias in trials and different types of 
comparisons to surgery, such as exercise therapy.
The panel used this evidence and followed BMJ Rapid Recommendations procedures for 
creating a trustworthy recommendation. This includes the GRADE approach. The panel met 
by videoconference to discuss the evidence and formulate a recommendation (see appendix 
2 on bmj.com).29 30 The panel considered the balance of benefits, harms, and burdens of 
surgery versus placebo surgery and nonoperative treatments, the certainty of the evidence 
for each outcome, typical and expected variations in patient values and preferences, as well 
as feasibility and acceptability (practical issues).23 Recommendations using GRADE can be 
strong or weak, for or against a course of action.30 The panel made the recommendation from 
an individual patient’s perspective assuming that all options were available and affordable to 
the patient. It does not take a public health, societal, or health payer perspective. Healthcare 
systems can adapt these recommendations by including costs and other key issues of 
relevance, contextualised to national and local circumstances.23
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Day surgery performed in an outpatient 
clinic
Need for outpatient visit to an orthopaedic 
surgeon before surgery
General anaesthesia and/or local nerve 
block during keyhole surgery. Recovery
period of 2-10 hours with numbness up to 
24 hours aer surgery
Recovery directly related to surgery takes 
four to six weeks. You may use a sling for 
a few days few days aer surgery
Avoid heavy liing for 7-21 days
Avoid overhead activities such as sports 
requiring shoulder use for 6 weeks and 
front crawl for 3 months
You may need someone to drive you 
home aer surgery
Recovery time varies from months to years
Out of pocket costs for surgery is 
generally high
Sick leave is typically offered the first few 
weeks aer surgery
You can start driving as soon as you feel 
able to steer, normally aer one week
Guided physical therapy and exercise 
programme offered at outpatient clinics, 
such as by physiotherapists. Other 
treatments may also be offered, such as  
NSAIDS or steroid injections in the shoulder
Guided physical therapy and exercise 
programme, performed at home with 
outpatient clinic visits every few weeks. 
Visit to general practitioner for referral may 
be needed
A guided physical therapy and exercise 
programme including information, advice, 
and supervised exercises. Exercises are also 
oen performed daily at home
Costs depend on health policy and health 
insurance
Potential sick leave depending on 
symptoms, kind of work, health care visits 













Fig 3 |  Practical issues for 
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The risk of serious harms after mixed shoulder arthro‑
scopic procedures was 0.5% (95% confidence interval 
0.4% to 0.7%) during years 2006‑11 and 0.6% (0.5% 
to 0.7%) during 2011‑13. Reported harms included 
events such as major bleeding, deep infections, serious 
anaesthetic complications, venous thromboembolism, 
and peripheral nerve injury. The indirectness caused by 
inclusion of mixed arthroscopic shoulder procedures in 
the registry study results in moderate certainty evidence 
for estimated harms.
Understanding the recommendation
The panel concluded that almost all well informed 
patients would decline surgery and therefore made a 
strong recommendation against subacromial decompres‑
sion surgery. The panel was confident that surgery pro‑
vides no important benefit on pain, function, quality of 
life, and global perceived effect informed by moderate to 
high certainty evidence in a one year timeframe. Surgery 
also comes with burdens and the risk of harm (see main 
infographic).
Clinicians should not offer patients subacromial decom‑
pression surgery unprompted, and clinicians, public 
healthcare providers, and others should make efforts to 
educate the public regarding the ineffectiveness of sur‑
gery. Although we did not take costs and resources into 
account beyond direct costs to patients (such as out‑of‑
pocket costs), surgery cannot be cost effective given the 
lack of important benefit, potential for harm, and associ‑
ated costs.
Figure 3 includes the practical issues linked to surgery, 
compared with physical therapy because this was the key 
comparison in the trials and a relevant treatment option. 
This would differ for other treatment options such as anal‑
gesia or injection.
Uncertainty
Clinicians and patients might question what other thera‑
pies could be offered to patients diagnosed with SAPS or 
rotator cuff disease and whether any therapy is effective. 
Here we recognise the limitation of our BMJ Rapid Recom‑
mendations, made to provide guidance on new evidence 
that might change practice. For guidance on treatment 
alternatives beyond surgery, we point readers to a clini‑
cally focused overview article and to guidelines with a 
broader scope (table 1).8
The whole area of best management of SAPS is uncer‑
tain, as reflected in the following brief summary on avail‑
able treatment options:
•   Glucocorticoid injections and NSAIDs may provide 
moderate to small short term benefits on shoulder 
pain compared with placebo.8 24
•   Exercise, manual therapy, and electrotherapies 
are of uncertain benefit to patients compared with 
watchful waiting, and guidelines vary in their 
recommendations.25 26
•   A holistic approach to care, with appropriate 
communication including reassurance and 
education, is likely to benefit patients but is poorly 
studied.27
Key research questions to inform decision makers and 
future guidelines include:
•   What are the best strategies to de‑implement 
inefficient and potentially harmful subacromial 
decompression surgery for SAPS?
•   How can we educate patients and clinicians to 
understand and adopt evidence, particularly when it 
goes against accepted beliefs?
Updates to this article
Table 2 shows evidence that has emerged since the 
p ublication of this article. As new evidence is published, 
a group will assess the new evidence and make a judge‑
ment on the extent it is expected to alter the recommen‑
dation.
Competing interests: All authors have completed the BMJ Rapid 
Recommendations interest disclosure form and a detailed, contextualised 
description of all disclosures is reported in appendix 1 on bmj.com. 
As with all BMJ Rapid Recommendations, the executive team and The 
BMJ judged that no panel member had any financial conflict of interest. 
Professional and academic interests are minimised as much as possible, 
while maintaining necessary expertise on the panel to make fully informed 
decisions.
Funding: The Dutch Orthopaedic Society has provided the MAGIC 
Foundation with €35 000 to support development of two rapid 
recommendations for orthopaedic surgery. The society had no role in the 
guideline development process for this BMJ Rapid Recommendation. The 
recommendation on shoulder surgery will be adapted into an updated 
recommendation in their guidelines.
Transparency: R Poolman and P O Vandvik affirm that the manuscript is an 
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(and, if relevant, registered) have been explained.
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There are currently no updates to the article.
EDUCATION INTO PRACTICE
• What would be your approach to managing subacromial 
pain syndrome (SAPS), based on the information you have 
read in this article?
• How can this article help you explain the new evidence to 
patients considering surgery for their shoulder pain? How 
should you respond if patients ask about surgery?
• What would you tell your colleagues about best practice for 
managing SAPS?
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